Emirati astronaut Sultan Al Neyadi has discussed the details of the “Cardinal Heart 2.0” study assigned to him at the International Space Station. The experiment, conducted by Stanford University, aims to investigate the effects of clinical drugs on heart cells in space in order to help prevent the risk of heart disease for astronauts. Al Neyadi added that the study might also make a contribution to the development of treatment for heart disease on Earth. The US space agency “NASA” has highlighted the importance of studying the human heart on the International Space Station due to the range of factors that can affect an astronaut’s general health and well-being. Al Neyadi has recently launched to the International Space Station as part of the Crew-6 mission and will undertake the longest scientific mission for the Arabs in space, participating in ten scientific experiments across ten vital areas over a six-month period.
Today, Monday, Emirati astronaut Sultan Al Neyadi revealed the details of one of the experiments assigned to him at the International Space Station.
Al-Neyadi said, on his official Twitter account, that one of the experiments entrusted to him is the “Cardinal Heart 2.0” study of Stanford University.
He added, “Through this experiment, we can learn regarding the effects of clinical drugs on heart cells in space, helping to prevent the risk of heart disease for astronauts.”
He pointed out that this experience will also contribute to the development of treatment for heart disease on Earth.
And the US space agency “NASA” says, “The human heart on the International Space Station is high on the list of concerns … where diseases or other factors such as aging that affect the heart can change a person’s general health and well-being.”
The Emirati astronaut, accompanied by the Crew-6 mission crew, successfully launched to the International Space Station a few days ago.
Al-Neyadi will undertake the longest scientific mission for the Arabs in space, which will last for six continuous months at the space station. He will participate in scientific experiments in ten vital areas throughout the duration of the mission.
With Emirati astronaut Sultan Al Neyadi’s participation in the “Cardinal Heart 2.0” study at the International Space Station, we can expect groundbreaking discoveries in heart disease treatment not only for astronauts but for people on Earth as well. As he embarks on his six-month scientific mission, we wait with bated breath for more updates on the experiments he will undertake and the contributions he will make to space exploration and medical research. Al Neyadi’s journey is not just a historic moment for the Arab world but for humanity as a whole, reminding us of the unlimited possibilities that await us beyond our planet.
